IMM 8.06% 33.5¢ immutep limited

worst corporate governance on the asx, page-101

  1. 4,906 Posts.
    lightbulb Created with Sketch. 343
    • The US FDA provides the highest hurdle standard globally for the
    approval of new drug and therapy treatments
    • Approvals process is a detailed and lengthy process, involving
    clinical trials over 3 phases and other FDA mandated requirements
    • Onerous processed highlighted by the fact the FDA only approved
    a total of 18 drugs last year
    • US FDA approval process is a major catalyst for Value for Prima
    Prima is in the final stages of its commercialisation timeline and will
    commence its Stage III Pivotal Clinical Trial with the US FDA midyear
    before seeking FDA approval to licence the product for
    commercial use


    http://www.primabiomed.com.au/projects/prodDocuments/PRR%20ASX%20Investor%20Presentation%2021April%2009.pdf
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
0.025(8.06%)
Mkt cap ! $486.6M
Open High Low Value Volume
32.0¢ 34.8¢ 31.3¢ $1.379M 4.179M

Buyers (Bids)

No. Vol. Price($)
8 170360 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 115131 3
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.